Inhibition of STAT3 prevents neointima formation by inhibiting proliferation and promoting apoptosis of neointimal smooth muscle cells

Human Gene Therapy

Volumn 14, Issue 7, 2003, Pages 601-610

  Shibata, Rei ^a   Kai, Hisashi ^a   Seki, Yukihiko ^a   Kato, Seiya ^a   Wada, Yoshihiro ^a   Hanakawa, Yasushi ^b   Hashimoto, Koji ^b   Yoshimura, Akihiko ^c   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BROXURIDINE; JANUS KINASE; MUTANT PROTEIN; PROTEIN BAX; PROTEIN BCL XL; PROTEIN MCL 1; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; CELL SURVIVAL; CONTROLLED STUDY; EARLY RESPONSE GENE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; MALE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

ADENOVIRIDAE; ANGIOPLASTY, BALLOON; ANIMALS; APOPTOSIS; ARTERIAL OCCLUSIVE DISEASES; BETA-GALACTOSIDASE; CELL DIFFERENTIATION; CELL DIVISION; DEFECTIVE VIRUSES; DNA-BINDING PROTEINS; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUNICA INTIMA;

ADENOVIRIDAE; ANIMALIA; JANUS;

EID: 0038407916     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403321618128     Document Type: Article

References (47)

1. BHAT, G.J., THEKKUMKARA, T.J., THOMAS, W.G., CONRAD, K.M., and BARKER, K.M. (1994). Angiotensin II stimulates sis-inducible factor-like DNA binding activity. J. Biol. Chem. 269, 31443-31449.
2. BROMBERG, J., and DARNELL, J.E. (2000). Role of STATs in transcriptional control and their impact on cellular function. Oncogene 19, 2468-2473.
3. CATLETT-FALCONE, R., LANDOWSKI, T.H., OSHIRO, M.M., TURKSON, J., LEVITZKI, A., SAVINO, R., CILIBERTO, G., MOSCINSKI, L., FERNANDEZ-LUNA, J.L., NUNEZ, G., DALTON, W.S., and JOVE, R. (1999). Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105-115.
4. CLOWES, A.W., REIDY, M.A., and CLOWES, M.M. (1983). Kinetics of cellular proliferation after arterial injury. I: Smooth muscle growth in the absence of endothelium. Lab. Invest. 49, 327-333.
5. COFFER, P., LUTTICKEN, C., VAN PUIJENBROEK, A., KROP-DE JONG, M., HORN, F., and KRUIJER, W. (1995). Transcriptional regulation of the junB promptor: Analysis of STAT-mediated signal transduction. Oncogene 10, 985-994.
6. DARNELL, J.E. (1997). STATs and gene regulation. Science 277, 1630-1635.
7. DIEZ, J., PANIZO, A., HERNANDEZ, M., and PARDO, J. (1997). Is the regulation apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats? Hypertension 29, 776-780.
8. DOLLEY, C.M., HUMPHRIES, S.E., MCCELLAND, A., LATCHMAN, D.S., and MCEWAN, J.R. (1999) Expression of tissue inhibitor of matrix metalloproteinases-1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. Circulation 99, 3199-3205.
9. EPLING-BURNETTE, P.K., LIU, J.H., CATLETT-FALCONE, R., TURKSON, J.O.M., KOTHAPALLI, R., LI, Y., WANG, J.M., YANG-YEN, H.F., KARRAS, J., JOVE, R., and LOUGHRAN, T.P. Jr. (2001). Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest. 107, 351-362.
10. FORCE, T., POMBO, C.M., AVRUCH, J.A., BONVENTRE, J.V., and KYRIAKIS, J.M. (1996). Stress-activated protein kinases in cardiovascular disease. Circ. Res. 78, 947-953.
11. GILMOUR, K.C., and REICH, N.C. (1995). Signal transduction and activation of gene transcription by interferons. Gene Exp. 5, 1-18.
12. GUZMAN, R.J., LEMARCHAND, P., CRYSTAL, R.G., EPSTEIN, S.E., and FINKEL, T. (1993). Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circ. Res. 88, 2838-2848.
13. HAN, D.K.M., HAUDENSCHILD, C.C., HONG, M.K., TINKLE, B.T., LEON, M.B., and LIAU, G. (1995). Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am. J. Pathol. 147, 267-277.
14. HSU, S.Y., and HSUEH, A.J. (2000). Tissue-specific Bcl-2 protein partners in apoptosis: An ovarian paradigm. Physiol. Rev. 80, 593-614.
15. ISNER, J.M., KEARNEY, M., BORTMAN, S., and PASSER, J. (1995). Apoptosis in human atherosclerosis and restenosis. Circulation 91, 2703-2711.
16. IZUMI, Y., KIM, S., NAMBA, M., YASUMOTO, H., MIYAZAKI, H., HOSHIGA, M., KANEDA, Y., MORISHITA, R., ZHAN, Y., and IWAO, H. (2001). Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ. Res. 88, 1120-1126.
17. KAI, H., GRIENDLING, K.K., LASSÉGUE, B., OLLERENSHAW, J.D., RUNGE, M.S., and ALEXANDER, R.W. (1994). Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor. Hypertension 24, 523-527.
18. KAI, H., GRIENDLING, K.K., LASSÉGUE, B., FUKUI, T., MINIERI, C.A., and ALEXANDER, R.W. (1996). Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11α-subunit in cultured vascular smooth muscle cells. Mol. Pharmacol. 49, 96-104.
19. KIM, S., IZUMI, Y., YANO, M., HAMAGUCHI, A., MIURA, K., YAMANAKA, S., MIYAZAKI, H., and IWAO, H. (1998) Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. Circulation 97, 1731-1737.
20. KOYAMA, H., OLSON, N.E., DASTVAN, F.F., and REIDY, M.A. (1998). Cell replication in the arterial wall. Activation of signaling pathway following in vivo injury. Circ. Res. 82, 713-721.
21. KUNUSADA, K., TONE, E., FUJIO, Y., MATSUI, H., YAMAUCHI-TAKIHARA, K., and KISHIMOTO, T. (1998). Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98, 346-352.
22. LIBBY, P., SCHWARTZ, D., BROGI, E., TANAKA, H., and CLINTON, S.K. (1992). A cascade model for restenosis: a special case of atherosclerosis progression. Circulation 86, III47-III52.
23. MARRERO, M.B., SCHIEFFER, B., PAXTON, W.G., HEERDT, L., BERK, B.C., DELAFONTAINE, P., and BERNSTEIN, K.E. (1995). Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375, 247-250.
24. MARRERO, M.B., SCHIEFFER, B., LI, B., SUN, J., HARP, J.B., and LING, B.N. (1997). Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol. Chem. 272, 24684-24690.
25. MIYAKE, S., MAKIMURA, M., KANEGAE, Y., HARADA, S., SATO, Y., TAKAMORI, K., TOKUDA, C., and SAITO, I. (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. U.S.A. 93, 1320-1324.
26. NAKASHIMA, K., YAMANAKA, Y., NAKAE, K., KOJIMA, H., ICHIBA, M., KIUCHI, N., KITAOKA, T., FUKADA, T., HIBI, M., and HIRANO, T. (1996). A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15, 3651-3658.
27. NIU, G., SHAIN, K.H., HUANG, M., RAVI, R., BEDI, A., DALTON, W.S., JOVE, R., and YU, H. (2001). Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cell leads to production of soluble factors that induce apoptosis and cell cycle arrest. Cancer Res. 61, 3276-3280.
28. OLTVAI, Z.N., and KORSMEYER, S. (1994). Checkpoints of dueling dimers foil death wishes. Cell 79, 189-192.
29. PERLMAN, H., MAILLARD, L., KRASINSKI, K., and WALSH, K. (1997). Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation 95, 981-987.
30. PERLMAN, H., SATA, M., LE ROUX, A., BRANELLEC, D., and WALSH, K. (1998). Bax-mediated cell death by the Gax homeoprotein requires mitogen activation but is independent of cell cycle activity. EMBO J. 17, 3537-3586.
31. PERLMAN, H., LUO, Z., KRASINSKI, K., LE ROUX, A., MAHFOULDI, A., SMITH, R.C., BRANELLEC, D., and WALSH, K. (1999). Adenovirus-mediated delivery of the Gax transcription factor to rat carotid arteries inhibits smooth muscle proliferation and induces apoptosis. Gene Ther. 6, 758-763.
32. POLLMAN, M.J., HALL, J.L., MANN, M.J., ZHANG, L., and GIBBONS, G.H. (1998). Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat. Med. 4, 222-227.
33. POLLMAN, M.J., HALL, J.L., and GIBBONS, G.H. (1999). Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Circ. Res. 84, 113-121.
34. ROSS, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809.
35. SAIURA, A., SATA, M., HIRATA, Y., NAGAI, R., and MAKUUCHI, M. (2001). Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat. Med. 7, 382-383.
36. SATA, M., SAIURA, A., KUNISATO, A., TOJO, A., OKADA, S., TOKUHISA, T., HIRAI, H., MAKUUCHI, M., HIRATA, Y., and NAGAI, R. (2002). Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8, 403-409.
37. SCHIEFFER, B., BERNSTEIN, K.E., and MARRERO, M.B. (1996). The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth. J. Mol. Med. 74, 85-91.
38. SCHWARTZ, R.S., HOLMES, D.S., and TOPOL, E.J. (1992). The restenosis paradigm revised: an alternative proposal for cellular mechanisms. J. Am. Coll. Cardiol. 20, 1284-1293.
39. SCHWARTZ, S.M., REIDY, M.A., and O'BRIEN, E.R.M. (1995). Assessment of factors important in atherosclerotic occlusion and restenosis. Thromb. Haemost. 74, 541-551.
40. SEKI, Y., KAI, H., SHIBATA, R., NAGATA, T., YASUKAWA, H., YOSHIMURA, A., and IMAIZUMI, T. (2000). Role of JAK/STAT pathway in rat carotid artery remodeling after vascular injury. Circ. Res. 87, 12-18.
41. SHIBATA, R., KAI, H., SEKI, Y., KATO, S., MORIMATSU, M., KAIBUCHI, K., and IMAIZUMI, T. (2001) Role of Rho-associated kinase in neointima formation after vascular injury. Circulation 103, 284-289.
42. SHOUDA, T., YOSHIDA, T., HANADA, T., WAKIOKA, T., OISHI, M., MIYOSHI, K., KOMIYA, S., KOSAI, K., HANAKAWA, Y., HASHIMOTO, K., NAGATA, K., and YOSHIMURA, A. (2001). Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J. Clin. Invest. 108, 1781-1788.
43. TULIS, D.A., MNJOYAN, Z.H., SCHIESSER, R.J., SHELAT, H.S., EVANS, A.J., ZOLDHELYI, P.Z., and FUJISE, K. (2003). Adenoviral gene transfer of fortilin attenuates neointima formation through suppression of vascular smooth muscle cell proliferation and migration. Circulation 107, 98-105.
44. UENO, H., LI, J.J., TOMITA, H., YAMAMOTO, H., PAN, Y., KANEGAE, Y., SAITO, I., and TAKESHITA, A. (1995). Quantitative analysis of repeated adenovirus-mediated gene transfer into injured canine femoral arteries. Arterioscler. Thromb. Vasc. Biol. 15, 2246-2253.
45. UENO, H., YAMAMOTO, H., ITO, S., LI, J.J., and TAKASHITA, A. (1997). Adenovirus-mediated transfer of a dominant negative H-ras suppresses neointimal formation in balloon-injured arteries in vivo. Arterioscler. Thromb. Vasc. Biol. 17, 898-904.
46. YASUKAWA, H., IMAIZUMI, T., MATSUOKA, H., NAKASHIMA, A., and MORIMATSU, M. (1997). Inhibition of intimal hyperplasia after balloon injury by antibodies to ICAM-1. Circulation 95, 1515-1522.
47. ZHONG, Z., WEN, Z., and DARNELL, J.E. (1994) STAT3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264, 95-98.